A new study from Yale researchers in Obstetrics and Gynecology shows no link between stillbirth and COVID-19 vaccines. Moreover, pregnant women who had received COVID-19 vaccines in pregnancy were at a decreased risk of preterm birth.
The authors say the findings should offer further reassurance that COVID-19 vaccination is safe and useful in pregnancy.
"The results of this robust case-control study can be used to reassure both pregnant patients and health care professionals that COVID-19 vaccination in pregnancy is not associated with an increased risk of pregnancy loss," said study author Anna Denoble, MD, in a press release.
The results of this robust case-control study can be used to reassure both pregnant patients and health care professionals
The study was based on outcomes seen in the Vaccine Safety Datalink, and compared receipt of the vaccine among women who had stillbirths or fetal death after 20 weeks gestation and those who had live births.
Vaccines not associated with any negative birth outcomes
A total of 55,591 people were included, and 23,517 (42.3%) received one or two mRNA COVID-19 vaccine doses during pregnancy.
Overall, 38.4% of patients experiencing stillbirth received a COVID-19 vaccine in pregnancy, compared with 39.3% of those with live births.
For pre-term birth, vaccinated women had a rate of 6.4 per 100, compared to 7.7 per 100 for unvaccinated. COVID-19 vaccines were not associated with preeclampsia, gestational hypertension, or small-for-gestational age neonates.
"Results from this study provide additional evidence regarding the safety of mRNA COVID-19 vaccine administration during pregnancy, the authors concluded.